Log In
Saturday 22nd October 2016

Cervical cancer jab effect underestimated

15th July 2010

The UK’s cervical cancer immunisation programme may offer better protection than initially thought. 

Research by the Health Protection Agency, the University of Manchester and the Manchester Royal Infirmary found the strains of human papillomavirus (HPV) targeted by the vaccine are responsible for a higher number of cases than expected.

The researchers have found that HPV 16 and 18 are actually responsible for between 73% and 77% of cases, suggesting that the vaccine could slash rates from about 3,000 to less than 700 a year.


Share this page


There are no comments for this article, be the first to comment!

Post your comment

Only registered users can comment. Fill in your e-mail address for quick registration.

Your email address:

Your comment will be checked by a Healthcare Today moderator before it is published on the site.

Mayden - Innovative cloud-based applications for healthcare
© Mayden Foundation 2016